132 related articles for article (PubMed ID: 30131267)
1. [Analysis of immune microenvironment by multiplex immunohistochemistry in locally advanced non-small cell lung cancer: Principles and perspectives].
Boulle G; Velut Y; Boni A; Lupo A; Alifano M; Trédaniel J; Giraud P; Damotte D
Cancer Radiother; 2018 Oct; 22(6-7):688-693. PubMed ID: 30131267
[TBL] [Abstract][Full Text] [Related]
2. [Overview of Multiplex Immunohistochemistry and Immunofluorescence Techniques
in the Lung Cancer Immunotherapy].
Sun W; Zhou J; Zhou J
Zhongguo Fei Ai Za Zhi; 2021 Jan; 24(1):36-42. PubMed ID: 33478189
[TBL] [Abstract][Full Text] [Related]
3. The Combination of New Immunotherapy and Radiotherapy: A N ew Potential Treatment for Locally Advanced Non-Small Cell Lung Cancer.
Sacco PC; Maione P; Guida C; Gridelli C
Curr Clin Pharmacol; 2017; 12(1):4-10. PubMed ID: 27908252
[TBL] [Abstract][Full Text] [Related]
4. Altered purinergic signaling in the tumor associated immunologic microenvironment in metastasized non-small-cell lung cancer.
Schmid S; Kübler M; Korcan Ayata C; Lazar Z; Haager B; Hoßfeld M; Meyer A; Cicko S; Elze M; Wiesemann S; Zissel G; Passlick B; Idzko M
Lung Cancer; 2015 Dec; 90(3):516-21. PubMed ID: 26505137
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated immune factors are associated with recurrence and metastasis in non-small cell lung cancer.
Yan X; Jiao SC; Zhang GQ; Guan Y; Wang JL
Cancer Gene Ther; 2017 Feb; 24(2):57-63. PubMed ID: 28084319
[TBL] [Abstract][Full Text] [Related]
6. B7-H3 in combination with regulatory T cell is associated with tumor progression in primary human non-small cell lung cancer.
Jin Y; Zhang P; Li J; Zhao J; Liu C; Yang F; Yang D; Gao A; Lin W; Ma X; Sun Y
Int J Clin Exp Pathol; 2015; 8(11):13987-95. PubMed ID: 26823710
[TBL] [Abstract][Full Text] [Related]
7. The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non-Small Cell Lung Cancer.
Bremnes RM; Busund LT; Kilvær TL; Andersen S; Richardsen E; Paulsen EE; Hald S; Khanehkenari MR; Cooper WA; Kao SC; Dønnem T
J Thorac Oncol; 2016 Jun; 11(6):789-800. PubMed ID: 26845192
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers.
Usó M; Jantus-Lewintre E; Bremnes RM; Calabuig S; Blasco A; Pastor E; Borreda I; Molina-Pinelo S; Paz-Ares L; Guijarro R; Martorell M; Forteza J; Camps C; Sirera R
Oncotarget; 2016 Aug; 7(33):52849-52861. PubMed ID: 27463005
[TBL] [Abstract][Full Text] [Related]
9. Towards effective immunotherapy for lung cancer: simultaneous targeting of tumor-initiating cells and immune pathways in the tumor microenvironment.
Dubinett S; Sharma S
Immunotherapy; 2009 Sep; 1(5):721-5. PubMed ID: 20636013
[No Abstract] [Full Text] [Related]
10. Composition of the immune microenvironment differs between carcinomas metastatic to the lungs and primary lung carcinomas.
Senarathne W; Vranic S; Xiu J; Rose I; Gates P; Gatalica Z
Ann Diagn Pathol; 2018 Apr; 33():62-68. PubMed ID: 29566951
[TBL] [Abstract][Full Text] [Related]
11. The immune microenvironments of lung and intraocular tumors.
Sautès-Fridman C; Dieu-Nosjean MC; Damotte D; Fisson S; Fridman WH
Bull Cancer; 2011 Jun; 98(6):58-61. PubMed ID: 21616749
[TBL] [Abstract][Full Text] [Related]
12. The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration.
Perea F; Bernal M; Sánchez-Palencia A; Carretero J; Torres C; Bayarri C; Gómez-Morales M; Garrido F; Ruiz-Cabello F
Int J Cancer; 2017 Feb; 140(4):888-899. PubMed ID: 27785783
[TBL] [Abstract][Full Text] [Related]
13. Advances in immunotherapy for non-small cell lung cancer.
Reckamp KL
Clin Adv Hematol Oncol; 2015 Dec; 13(12):847-53. PubMed ID: 27058851
[TBL] [Abstract][Full Text] [Related]
14. The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer.
Bremnes RM; Al-Shibli K; Donnem T; Sirera R; Al-Saad S; Andersen S; Stenvold H; Camps C; Busund LT
J Thorac Oncol; 2011 Apr; 6(4):824-33. PubMed ID: 21173711
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic heterogeneity studied by immunohistochemistry and aneuploidy in non-small cell lung cancers.
Pujol JL; Simony J; Laurent JC; Richer G; Mary H; Bousquet J; Godard P; Michel FB
Cancer Res; 1989 May; 49(10):2797-802. PubMed ID: 2540908
[TBL] [Abstract][Full Text] [Related]
16. Antigen-Presenting Intratumoral B Cells Affect CD4
Bruno TC; Ebner PJ; Moore BL; Squalls OG; Waugh KA; Eruslanov EB; Singhal S; Mitchell JD; Franklin WA; Merrick DT; McCarter MD; Palmer BE; Kern JA; Slansky JE
Cancer Immunol Res; 2017 Oct; 5(10):898-907. PubMed ID: 28848053
[TBL] [Abstract][Full Text] [Related]
17. Interaction between neoplastic cells and cancer-associated fibroblasts through the CXCL12/CXCR4 axis: role in non-small cell lung cancer tumor proliferation.
Wald O; Izhar U; Amir G; Kirshberg S; Shlomai Z; Zamir G; Peled A; Shapira OM
J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1503-12. PubMed ID: 21463876
[TBL] [Abstract][Full Text] [Related]
18. [Stage IIIB non-small cell lung cancer. Optimization of radiotherapy in lung cancer: some interesting questions to be solved].
Girard N; Mornex F
Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S61-16S67. PubMed ID: 17268338
[TBL] [Abstract][Full Text] [Related]
19. Density of tumor-infiltrating FOXP3+ T cells as a response marker for induction chemoradiotherapy and a potential prognostic factor in patients treated with trimodality therapy for locally advanced non-small cell lung cancer.
Tao H; Shien K; Soh J; Matsuda E; Toyooka S; Okabe K; Miyoshi S
Ann Thorac Cardiovasc Surg; 2014; 20(6):980-6. PubMed ID: 24583705
[TBL] [Abstract][Full Text] [Related]
20. Different morphology, stage and treatment affect immune cell infiltration and long-term outcome in patients with non-small-cell lung carcinoma.
da Costa Souza P; Parra ER; Atanazio MJ; da Silva OB; Noleto GS; Ab'Saber AM; de Morais Fernezlian S; Takagaki T; Capelozzi VL
Histopathology; 2012 Oct; 61(4):587-96. PubMed ID: 22716510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]